Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - BiotechnologySector: Health Care
Stock price data as of 12/31/2020
Closing price: 58.26
Support price level: | N/A |
Resistance price level: | $59.13 |
Relative strength index (14-day RSI) | 34.5 |
Beta | 0.39 |
- GILD is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.
- GILD is one of this month's worst performers with a return of -4.7%, underperforming 90 percent of stocks in the S&P-100.
- The price of this low-beta stock is expected to increase by 0.39% for every 1% increase in the S&P-500.
- Volatility is forecast to rise over the next month.
- Price broke below prior support level - a short-term bearish signal.
Low | High | Price as % of Range |
$56.65 | $84.00 | 7.1% |
200 day | 50 day | 20 day | 10 day |
$68.97 | $59.62 | $59.07 | $57.68 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
27.6% | 21.8% | 21.3% | 26.8% |
- 5.8% in the next week.
- 15.2% in the next month.
- 61.2% in the next year.
Company news for Gilead Sciences Inc
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks